Stay updated on Pembrolizumab in Untreated Extensive SCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.

Latest updates to the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page
- Check6 days agoChange DetectedRevision indicator on the page updated from v3.6.0 to v3.6.2, indicating a newer version of the page content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, and the Intervention / Treatment heading was updated to Intervention/Treatment with a page revision tag showing v3.6.0. The recruitment status was updated to No longer looking for participants, indicating enrollment is closed.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now shows revision v3.5.5, indicating a backend/update of the page template. It represents a backend refresh rather than a modification to the study information displayed.SummaryDifference0.0%

- Check49 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4. This reflects a new version of the page in the content management system.SummaryDifference0.0%

- Check63 days agoChange DetectedA revision tag on the page was updated from v3.5.2 to v3.5.3, indicating a system update; study content and displayed information remain unchanged.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Untreated Extensive SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.